Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Type-IV collagen related diseases.

Chiara Pescucci1, Ilaria Longo, Mirella Bruttini

  • 1Medical Genetics, Department of Molecular Biology, Policlinico Le Scotte, University of Siena, Viale Bracci 2, 53100 Siena, Italy.

Journal of Nephrology
|May 28, 2003
PubMed
Summary

Alport syndrome (ATS) is a rare inherited kidney disease caused by genetic mutations. Understanding the different inheritance patterns, including X-linked and autosomal forms, is crucial for diagnosis and management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registry.

Frontiers in immunology·2026
Same author

Expanding the ABCA2-associated neurodevelopmental phenotype.

HGG advances·2026
Same author

RNU4ATAC-opathy: Clinical, molecular and transcriptomic insights from a large cohort.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

The perfect storm: autoinflammation, metabolic stress, and thrombolysis in bilateral carotid dissection-a case report.

Journal of neurology·2026
Same author

Novel <i>NFIX</i> variant in a patient with Malan syndrome and associated Chiari type I malformation: a case report.

Frontiers in pediatrics·2026
Same author

Longitudinal Whole-Exome Sequencing of Cell-Free DNA Reveals Molecular Evolution and Heterogeneous Clinical Outcomes in PD-L1 Stratified Advanced NSCLC Adenocarcinoma Patients Treated with Atezolizumab.

International journal of molecular sciences·2026

Area of Science:

  • Nephrology
  • Genetics
  • Molecular Biology

Background:

  • Alport syndrome (ATS) is a progressive inherited glomerulonephritis affecting 1-2% of patients requiring renal replacement therapy.
  • It is genetically heterogeneous, primarily X-linked (COL4A5 mutations), but also autosomal (COL4A3/COL4A4 mutations).
  • The X-linked form typically affects males more severely than females, though some females progress to end-stage renal disease.

Purpose of the Study:

  • To elucidate the genetic heterogeneity of Alport syndrome.
  • To differentiate clinical manifestations based on inheritance patterns (X-linked, autosomal recessive, autosomal dominant).
  • To understand the spectrum of kidney disease, including benign familial hematuria.

Main Methods:

  • Genetic analysis of COL4A5, COL4A3, and COL4A4 genes.

Related Experiment Videos

  • Clinical phenotyping of patients with Alport syndrome and related conditions.
  • Correlation of genotype with disease severity and progression.

    • Main Results:

    • Mutations in COL4A3 or COL4A4 can cause autosomal recessive ATS, autosomal dominant ATS with slow progression, or benign familial hematuria (BFH).
    • Females with X-linked ATS are generally less affected, with microhematuria, but ~30% may develop end-stage renal disease.
    • The study highlights the diverse clinical presentations stemming from different genetic mutations in Alport syndrome.

    Conclusions:

    • Alport syndrome exhibits significant genetic heterogeneity with varied inheritance patterns.
    • Mutations in COL4A3/COL4A4 contribute to a broader spectrum of kidney diseases than previously recognized.
    • Accurate genetic diagnosis is essential for predicting disease progression and managing patients with Alport syndrome and related disorders.